Medicare Enrolled
Dr. Mobeen Choudhri, MD
Interventional Pain Medicine Physician · Bellaire, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Choudhri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Choudhri? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Choudhri
Dr. Mobeen Choudhri is an interventional pain medicine physician in Bellaire, TX, with 19 years in practice. Based on federal Medicare data, Dr. Choudhri performed 3,957 Medicare services across 2,554 unique beneficiaries.
Between the years covered by Open Payments, Dr. Choudhri received a total of $66,384 from 72 pharmaceutical and/or device companies across 1591 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Choudhri is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 23% volume in TX$ $66,384 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,957
Medicare services
Top 23% in TX for interventional pain medicine physician
2,554
Unique beneficiaries
$120
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~208 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test | 857 | $61 | $287 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 520 | $194 | $795 |
| Office visit, established patient (30-39 min) | 444 | $92 | $434 |
| Steroid injection (triamcinolone) | 363 | $1 | $56 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 141 | $142 | $896 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 132 | $240 | $988 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 123 | $152 | $626 |
| Fluoroscopic guidance for needle placement | 122 | $88 | $417 |
| Office visit, established patient (20-29 min) | 115 | $63 | $295 |
| Joint injection, major joint | 109 | $53 | $296 |
| Dexamethasone injection (steroid) | 107 | $0 | $5 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 97 | $188 | $1,358 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 96 | $100 | $684 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 78 | $195 | $1,097 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 66 | $88 | $438 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 65 | $267 | $1,329 |
| New patient office visit (45-59 min) | 64 | $116 | $669 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 63 | $476 | $3,216 |
| Injection, methylprednisolone acetate, 40 mg | 61 | $6 | $9 |
| Injection of substance into lower spine canal using imaging guidance | 58 | $177 | $1,037 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 52 | $103 | $684 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 51 | $198 | $1,372 |
| Injection of substance into middle or upper spine canal using imaging guidance | 35 | $194 | $967 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 31 | $472 | $3,136 |
| Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | 30 | $698 | $3,050 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 29 | $285 | $1,426 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 24 | $74 | $391 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 13 | $177 | $958 |
| Nerve conduction, 9-10 studies | 11 | $148 | $967 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$66,384
Total received (2018-2024)
Avg $9,483/year across 7 years
Top 4% in TX for interventional pain medicine physician
72
Companies
1,591
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$66,384 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$8,537
2023$9,347
2022$6,047
2021$8,586
2020$6,862
2019$14,815
2018$12,188
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$15,905
Abbott Laboratories
$6,397
Medtronic USA, Inc.
$5,741
Boston Scientific Corporation
$5,224
SI-BONE, Inc.
$4,026
SI-BONE, INC.
$3,046
BOSTON SCIENTIFIC CORPORATION
$2,899
Nuvectra Corporation
$2,591
Nevro Corp.
$2,159
Saluda Medical Americas, Inc.
$2,083
PFIZER INC.
$1,825
Medtronic Vascular, Inc.
$1,629
Relievant Medsystems, Inc.
$1,228
Vertos Medical, Inc.
$987
Teva Pharmaceuticals USA, Inc.
$968
Amgen Inc.
$743
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$628
Collegium Pharmaceutical, Inc.
$623
AbbVie Inc.
$582
Pacira Pharmaceuticals Incorporated
$510
ABBVIE INC.
$480
Daiichi Sankyo Inc.
$463
Allergan Inc.
$389
Lilly USA, LLC
$373
Horizon Therapeutics plc
$284
Eisai Inc.
$276
Novartis Pharmaceuticals Corporation
$263
Allergan, Inc.
$250
ARBOR PHARMACEUTICALS, INC.
$235
SCILEX PHARMACEUTICALS INC.
$232
Bioventus LLC
$201
BioDelivery Sciences International, Inc.
$188
Scilex Pharmaceuticals Inc.
$174
Takeda Pharmaceuticals U.S.A., Inc.
$160
Merz North America, Inc.
$160
Merz Pharmaceuticals, LLC
$158
Zynex Medical, Inc.
$155
Stryker Corporation
$139
Lundbeck LLC
$125
Biohaven Pharmaceutical Holding Company Ltd.
$119
Nalu Medical, Inc.
$119
Egalet US Inc
$118
Electronic Waveform Lab, Inc.
$104
Globus Medical, Inc.
$103
MERZ NORTH AMERICA, INC.
$102
TerSera Therapeutics LLC
$98
PAINTEQ LLC
$96
FUJIFILM SonoSite, Inc.
$95
Flexion Therapeutics, Inc.
$92
Averitas Pharma Inc.
$87
IDORSIA PHARMACEUTICALS US INC
$65
Pernix Therapeutics Holdings, Inc.
$61
Supernus Pharmaceuticals, Inc.
$61
US WorldMeds, LLC
$59
AstraZeneca Pharmaceuticals LP
$53
Arbor Pharmaceuticals, Inc.
$49
EISAI INC.
$46
Sentynl Therapeutics, Inc.
$40
ASSERTIO THERAPEUTICS, Inc.
$38
Shionogi Inc
$36
Zyla Life Sciences
$35
Tactile Systems Technology Inc
$30
IMPEL PHARMACEUTICALS INC.
$30
Bausch Health US, LLC
$29
Avanos Medical
$26
GRT US Holding, Inc.
$24
Zyla Life Sciences, Inc.
$17
Kaleo, Inc.
$13
Horizon Pharma plc
$12
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$11
Vertiflex, Inc.
$11
BIOCOMPOSITES INC
$10
Top 3 companies account for 42.2% of total payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · AJOVY · ARYMO ER · AUTOFILL · AXIUM · Accurian · Aimovig · Algovita · Amitiza · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · COLOGUARD · COMIRNATY · COOLIEF COOLED RADIOFREQUENCY · CREO · ClosureFast · DUEXIS · Dayvigo · Durolane · EMBEDA · EMGALITY · ETERNA · EUCRISA · Evoke · Evoke SCS · Evzio · Exparel · FIXATE · Flexitouch Plus · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · Gralise · Horizant · IFUSE IMPLANT · IFUSE IMPLANT SYSTEM · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - MULTIGEN 2RF · Intracept · Iovera System · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LUCEMYRA · LYRICA · Levorphanol · Lucemyra · Lucemyra/Lofexidine · MIDAS REX · MIGRANAL · MILD DEVICE KIT · MOVANTIK · Morphabond ER · NURTEC ODT · Nalu Neurostimulation System · Nexwave · OCTRODE · OSTEOCOOL RF ABLATION SYSTEM · Omnia · PAINTEQ · PENNSAID · PRIALT · PROCLAIM · PRODIGY · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · S Series Ultrasound System · SCS IPGs · SPECTRA WAVEWRITER · SPRIX · STIMROUTER IMPLANTABLE KIT · STIMULAN · SUPERION · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TROKENDI XR · Trudhesa · UBRELVY · V-LOC 180 · VANTA ADAPTIVESTIM · VECTRIS · VYEPTI · Vanta · VenaSeal · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · XTAMPZAER · Xeomin · Xtampza ER · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for interventional pain medicine physician in TX.
Equivalent to $1,678 per 100 Medicare services performed
Geographic Context
Interventional Pain Medicine Physicians within 10 mi
28
Per 100K population
0.6
County median income
$73,104
Nearest hospital
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Choudhri is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX), and high industry engagement (low-engagement, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Choudhri experienced with drug screening test?
Based on Medicare claims data, Dr. Choudhri performed 857 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Choudhri receive payments from pharmaceutical companies?
Yes. Dr. Choudhri received a total of $66,384 from 72 companies across 1,591 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Choudhri's costs compare to other interventional pain medicine physicians in Bellaire?
Dr. Choudhri's average Medicare payment per service is $120. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Choudhri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Bellaire
Browse interventional pain medicine physicians in Bellaire ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in TX
Interventional Pain Medicine Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in TX
Which TX interventional pain medicine physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology